All filters
Slidesets
Examples of missed opportunities in avoiding long term toxicities and comorbidities | Yazdan Yazdanpanah, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Development of an innovative mHealth application to support selfmanagement strategies for people living with HIV | Dr D. Brown
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Online sexual health intervention to support MSM directly after HIV diagnosis -The experiences of www.4mezelf.nl | Dr U. Davidovich
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
What “good” looks like. Enhancing the well-being of people with HIV through a Peer Navigator Service | Dr J. Anderson
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Missed the PrEP opportunity? | Laura Waters, MD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
PrEP: who, when and how | Anton Pozniak, MD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Clinical Implications of Cabotegravir Plasma Levels - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
DDIs Relevant for COVID-19 Therapeutic Agents & Implementation Challenges - Fiona Marra, MPharm, MSc
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Emerging Strategies for Treating and Preventing Monkeypox 2022 - Ruth Byrne, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Long-acting Cabotegravir Pharmacokinetics With and Without Oral Lead-in for HIV PrEP - Kelong Han
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
CabotegravirRilpivirine Failures Despite Adherence Slides - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Deep Learning Ensemble Classifier to Predict Drug-Drug Interaction - Thao Pham
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Islatravir Toxicity Slides - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Lenacapavir Considerations - Jonathan Schapiro, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Optimization of Pharmacology Studies and DDIs in Pregnant and Lactating Individuals - Angela Colbers, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Pharmacology Pearls for Managing Absorption and Swallowing Difficulties - Saye Khoo, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Slidesets
Strategies to Improve Delivery to Reservoirs as Targets for Long-Acting Antivirals - Adeniyi Olagunju, BPharm, MRes, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022